Clinical trials: Bronchial Blocker
Non Small Cell Lung Carcinoma, Renal Cell Carcinoma
Retifanlimab and Ruxolitinib In Solid Malignancies
The goal of this clinical trial is to learn what dose of ruxolitinib can be given safely together with retifanlimab in patients with metastatic renal cell carcinoma and non-small cell lung carcinoma.
- Trial name
- PRISM (NCT07219576)
- Testing
- Ruxolitinib, Retifanlimab
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, San Diego
Pneumothorax
Disconnection Technique With a Bronchial Blocker for Improving Lung Deflation
One lung ventilation (OLV) is accomplished with a double lumen tube (DLT) or a bronchial blocker (BB). In this study, the investigators compared the effectiveness of lung collapse using DLT, BB with spontaneous collapse, and BB…
- Trial name
- NCT01846936
- Testing
- DLT with conventional technique, BB with conventional technique, Disconnection technique
- Where
- South Korea
- Volunteers
- 54 people
- Sponsor
- Ajou University School of Medicine